Related Experiment Video
Updated: May 13, 2026
06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Prognostic factors in myelodysplastic syndromes
Irina Triantafyllidis1, Anca Ciobanu, Oana Stanca
1Coltea Clinical Hospital, Department of Hematology Bucharest, Romania.
Maedica
|March 14, 2013
Summary
Prognostic factors like bone marrow blasts and cytogenetic abnormalities significantly impact outcomes in myelodysplastic syndromes (MDS). These factors predict survival, leukemia transformation, and bone marrow failure complications in MDS patients.
Area of Science:
- Hematology
- Oncology
Background:
- Myelodysplastic syndromes (MDS) are clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis, leading to bone marrow failure and potential transformation to acute myeloid leukemia.
- MDS exhibits significant heterogeneity, necessitating accurate prognostic factors for optimal therapeutic decisions and patient management.
Purpose of the Study:
- To analyze key prognostic factors influencing patient outcomes in myelodysplastic syndromes.
- To evaluate the predictive value of cytopenias, bone marrow blast percentage, and cytogenetic abnormalities on survival and disease progression.
Main Methods:
- A cohort of 119 de novo myelodysplastic syndromes patients diagnosed between 2008-2011 was studied.
- Patients were stratified based on the French-American-British (FAB) morphologic classification.
- Prognostic factors analyzed included cytopenias, bone marrow blast percentage, cytogenetic abnormalities, anemia intensity, and transfusional dependence.
Main Results:
- Patient outcomes in MDS are significantly influenced by the percentage of bone marrow blasts at diagnosis.
- The number and severity of hematopoietic lineages affected by cytopenia are critical determinants of prognosis.
- The presence of chromosomal abnormalities strongly correlates with patient outcomes.
Conclusions:
- The analyzed prognostic factors demonstrate predictive value for survival and leukemic transformation in MDS.
- These factors are crucial for predicting treatment response and the development of bone marrow failure complications.
- Accurate prognostication aids in tailoring treatment strategies and managing complications in myelodysplastic syndromes.
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...